Kymera Therapeutics
KYMR
KYMR
126 hedge funds and large institutions have $1.68B invested in Kymera Therapeutics in 2023 Q1 according to their latest regulatory filings, with 16 funds opening new positions, 46 increasing their positions, 41 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
12% more repeat investments, than reductions
Existing positions increased: 46 | Existing positions reduced: 41
6% more funds holding
Funds holding: 119 → 126 (+7)
0.76% more ownership
Funds ownership: 102.29% → 103.04% (+0.76%)
Holders
126
Holding in Top 10
6
Calls
$22M
Puts
$2.6M
Top Buyers
| 1 | +$12.6M | |
| 2 | +$10M | |
| 3 | +$8.52M | |
| 4 |
WA
Wasatch Advisors
Salt Lake City,
Utah
|
+$6.08M |
| 5 |
Invesco
Atlanta,
Georgia
|
+$5.21M |
Top Sellers
| 1 | -$8.89M | |
| 2 | -$7.79M | |
| 3 | -$5.77M | |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
-$5.29M |
| 5 |
AVLSA
Atlas Venture Life Science Advisors
Cambridge,
Massachusetts
|
-$3.75M |